N-(5-氯苯并[d][1,3]二氧杂环戊烯-4-基)-7-(2-(4-甲基哌嗪-1-基)乙氧基)-5-((四氢-2H-吡喃-4-氧基))喹唑啉-4-胺

中文名称：N-(5-氯苯并[d][1,3]二氧杂环戊烯-4-基)-7-(2-(4-甲基哌嗪-1-基)乙氧基)-5-((四氢-2H-吡喃-4-氧基))喹唑啉-4-胺
CAS号：379231-04-6
中文别名：塞卡替尼;N-(5-氯-1,3-苯并二氧戊环-4-基)-7-[2-(4-甲基-1-哌嗪基)乙氧基]-5-[(四氢-2H-吡喃-4-基)氧基]-4-喹唑啉胺;Saracatinib (AZD0530) 抑制剂;西地尼布cediranibAZD2171;塞卡替尼  
英文名称：Saracatinib
英文别名：Saracatinib;N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine;Saracatinib (AZD0530);(S)-2-[4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide;4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(...;4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-;AZD0530;N-(5-Chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;Saracatinib (AZD0530, AZD-0530 );Saracatinib-AZD0530; AZD-0530;AZD0530 difuMarate;AZD 0530;SARACATINIB, FREE BASE;9KD24QGH76;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine;4-(6-Chloro-;4-(6-Chloro-2,3-methylenedioxyanili;HMS3265E21;N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-[(oxan-4-yl)oxy]quinazolin-4-amine;HMS3265E22;379231-04-6;Saracatinib [USAN:INN];nchembio866-comp19;UNII-9KD24QGH76;NSC758872;DTXSID90191355;HMS3884A03;GTPL7731;NCGC00241099-01;CHEMBL217092;saracatinibum;CCG-264773;SB16503;Q-201699;HMS3654K03;BCP0726000126;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;OUKYUETWWIPKQR-UHFFFAOYSA-N;4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline;N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine;N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-(2-(4-METHYLPIPERAZIN-1-YL)ETHOXY)-5-((OXAN-4-YL)OXY)QUINAZOLIN-4-AMINE;N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;CS-0101;2h8h;AZD0350;NS00071732;NSC-800878;HMS3265F22;A823939;FT-0657225;SMR004702935;s1006;SARACATINIB [WHO-DD];4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline;NSC800878;AC-5249;Q21098957;NCGC00241099-06;SW218134-2;D09664;SCHEMBL41547;HMS3265F21;HMS3747A05;AS-16692;MLS006011166;Saracatinib [USAN];N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxy-quinazolin-4-amine;SARACATINIB [INN];N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;NCGC00241099-03;DB11805;EX-A1576;BCPP000364;N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4-amine;BCP9000358;HY-10234;CHEBI:47458;BRD-K19540840-001-05-2;NSC-758872;AZD-0530;N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxy-quinazolin-4-amine;Saracatinib,AZD0530;AZ-1035...
EINEC:
分子式：C27H32CLN5O5
分子量：542.0265 N-(5-氯苯并[d][1,3]二氧杂环戊烯-4-基)-7-(2-(4-甲基哌嗪-1-基)乙氧基)-5-((四氢-2H-吡喃-4-氧基))喹唑啉-4-胺